ECSP10010249A - Tratamiento de cardiopatías usando -bloqueantes - Google Patents
Tratamiento de cardiopatías usando -bloqueantesInfo
- Publication number
- ECSP10010249A ECSP10010249A EC2010010249A ECSP10010249A ECSP10010249A EC SP10010249 A ECSP10010249 A EC SP10010249A EC 2010010249 A EC2010010249 A EC 2010010249A EC SP10010249 A ECSP10010249 A EC SP10010249A EC SP10010249 A ECSP10010249 A EC SP10010249A
- Authority
- EC
- Ecuador
- Prior art keywords
- cardiopathies
- blockers
- treatment
- reversing
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
La presente invención se refiere a un procedimiento para revertir la remodelación cardiaca electrofisiológica de animales con cardiopatía. Más específicamente, el procedimiento incluye administrar a un animal que lo necesite un bloqueante de adrenoceptores .
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1689107P | 2007-12-27 | 2007-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010249A true ECSP10010249A (es) | 2010-07-30 |
Family
ID=40456577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010249A ECSP10010249A (es) | 2007-12-27 | 2010-06-14 | Tratamiento de cardiopatías usando -bloqueantes |
Country Status (19)
Country | Link |
---|---|
US (1) | US20100305213A1 (es) |
EP (1) | EP2234609A1 (es) |
JP (1) | JP2011507918A (es) |
KR (1) | KR20100102640A (es) |
CN (1) | CN101909612A (es) |
AU (1) | AU2008342250A1 (es) |
BR (1) | BRPI0821483A2 (es) |
CA (1) | CA2710665A1 (es) |
CO (1) | CO6300936A2 (es) |
CR (1) | CR11501A (es) |
EC (1) | ECSP10010249A (es) |
IL (1) | IL205870A0 (es) |
MX (1) | MX2010006443A (es) |
NI (1) | NI201000096A (es) |
RU (1) | RU2010131022A (es) |
SV (1) | SV2010003595A (es) |
TW (1) | TW200942227A (es) |
WO (1) | WO2009083177A1 (es) |
ZA (1) | ZA201003867B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013113148A1 (zh) * | 2012-01-30 | 2013-08-08 | Lin Shuguang | β3肾上腺素受体阻滞剂的抗肿瘤用途 |
JP6772430B2 (ja) | 2015-03-03 | 2020-10-21 | サニオナ・エー/エス | テソフェンシンとベータブロッカーの合剤 |
US11235029B2 (en) | 2017-03-09 | 2022-02-01 | Temple University-Of The Commonwealth System of Higher | Methods for treating heart failure with a TRKB agonist |
EP3768378A4 (en) | 2018-03-22 | 2021-11-17 | InCarda Therapeutics, Inc. | INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE |
CN110269938A (zh) * | 2019-06-27 | 2019-09-24 | 山东省眼科研究所 | 一种减轻铜绿假单胞菌性角膜炎症的药物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
DE102006020604A1 (de) * | 2006-05-02 | 2007-11-08 | Bayer Healthcare Ag | Flüssige Arzneimittelformulierung |
-
2008
- 2008-12-19 AU AU2008342250A patent/AU2008342250A1/en not_active Abandoned
- 2008-12-19 MX MX2010006443A patent/MX2010006443A/es not_active Application Discontinuation
- 2008-12-19 WO PCT/EP2008/010892 patent/WO2009083177A1/en active Application Filing
- 2008-12-19 CA CA2710665A patent/CA2710665A1/en not_active Abandoned
- 2008-12-19 RU RU2010131022/15A patent/RU2010131022A/ru unknown
- 2008-12-19 KR KR1020107015059A patent/KR20100102640A/ko not_active Application Discontinuation
- 2008-12-19 CN CN2008801231805A patent/CN101909612A/zh active Pending
- 2008-12-19 EP EP08869096A patent/EP2234609A1/en not_active Withdrawn
- 2008-12-19 BR BRPI0821483-2A patent/BRPI0821483A2/pt not_active IP Right Cessation
- 2008-12-19 US US12/745,679 patent/US20100305213A1/en not_active Abandoned
- 2008-12-19 JP JP2010540055A patent/JP2011507918A/ja active Pending
- 2008-12-26 TW TW097150783A patent/TW200942227A/zh unknown
-
2010
- 2010-05-20 IL IL205870A patent/IL205870A0/en unknown
- 2010-05-31 ZA ZA2010/03867A patent/ZA201003867B/en unknown
- 2010-06-09 NI NI201000096A patent/NI201000096A/es unknown
- 2010-06-11 SV SV2010003595A patent/SV2010003595A/es not_active Application Discontinuation
- 2010-06-11 CO CO10071046A patent/CO6300936A2/es not_active Application Discontinuation
- 2010-06-14 EC EC2010010249A patent/ECSP10010249A/es unknown
- 2010-06-14 CR CR11501A patent/CR11501A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2009083177A1 (en) | 2009-07-09 |
KR20100102640A (ko) | 2010-09-24 |
CR11501A (es) | 2010-11-12 |
JP2011507918A (ja) | 2011-03-10 |
CA2710665A1 (en) | 2009-07-09 |
US20100305213A1 (en) | 2010-12-02 |
EP2234609A1 (en) | 2010-10-06 |
AU2008342250A1 (en) | 2009-07-09 |
IL205870A0 (en) | 2010-11-30 |
ZA201003867B (en) | 2011-08-31 |
SV2010003595A (es) | 2011-01-14 |
BRPI0821483A2 (pt) | 2015-06-16 |
NI201000096A (es) | 2011-03-23 |
TW200942227A (en) | 2009-10-16 |
CN101909612A (zh) | 2010-12-08 |
CO6300936A2 (es) | 2011-07-21 |
RU2010131022A (ru) | 2012-02-10 |
MX2010006443A (es) | 2010-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122964T1 (el) | Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων | |
ECSP11010831A (es) | Compuestos orgánicos para la cicatrización de heridas | |
EA201290078A1 (ru) | Гетероциклические соединения для ингибирования pask | |
EA201190280A1 (ru) | Производные l-(пиперидин-4-ил)пиразола в качестве модуляторов gpr 119 | |
CY1115902T1 (el) | Συνδυαστικη θεραπεια καρκινου με ανασταλτικες ενωσεις hps90 | |
UY34165A (es) | ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?. | |
UY32030A (es) | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" | |
EA201000559A1 (ru) | Композиции и способы применения антител к склеростину | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
GT200600092A (es) | Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer | |
EA201170042A1 (ru) | Композиции для осветления цвета кожи | |
CR9753A (es) | Agente terapeutico para diabetes | |
BRPI0915112A2 (pt) | cateter de entalhe para tratar válvulas cardíacas doentes | |
EA201101037A1 (ru) | Лечение диабета у пациентов с неадекватным гликемическим контролем, несмотря на лечение метформином | |
ECSP20046463A (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
CY1117603T1 (el) | Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2 | |
BRPI0911577A2 (pt) | derivados espiro-indol para o tratamento de doenças parasíticas. | |
BR112012017994B8 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio | |
AR092899A1 (es) | Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion | |
ECSP10010249A (es) | Tratamiento de cardiopatías usando -bloqueantes | |
CR20110660A (es) | Mezclas fungicidas | |
CY1112058T1 (el) | Χρηση των χιτοζανων για την αυξηση του βαθμου αναπτυξης των νυχιων | |
AR086240A1 (es) | Composiciones que comprenden un antimetabolito de glucosa, bha y/o bht |